您当前的位置：
首页 >
文章列表页 >
Current status and perspectives on conversion therapy for hepatocellular carcinoma in the era of targeted immunotherapy
更新时间：2026-11-05

    • Current status and perspectives on conversion therapy for hepatocellular carcinoma in the era of targeted immunotherapy

    • J Abdominal Surg   Vol. 38, Issue 5, Pages: 346-351(2025)

    • DOI：10.3969/j.issn.1003-5591.2025.05.003    

      CLC： R735.7

    • Received：05 August 2025，

      Published：22 October 2025

    移动端阅览

  • Li Xin,Cai Changchun.Current status and perspectives on conversion therapy for hepatocellular carcinoma in the era of targeted immunotherapy[J].J Abdominal Surg,2025,38(05):346-351. DOI： 10.3969/j.issn.1003-5591.2025.05.003.

  •  
  •  

0

Views

2

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Several outstanding issues for conversion therapy of liver cancer
Clinical decision on surgical resection for patients with complete response after conversion therapy for hepatocellular carcinoma： controversy and consensus
Current status and analysis of combined therapy based on the hepatic arterial infusion chemotherapy for middle-stage and advanced hepatocellular carcinoma
Efficacy analysis of subsegmental ablation for hepatocellular carcinoma based on the portal venous territory
Current status and advances in imaging in the full-course management of local therapy for hepatocellular carcinoma

Related Author

Yuan Yufeng
Zhang Zhonglin
Chen Yajin
Luo Xuan
Wang Zhengwen
Xu Shengjiang
Wang Xianzheng
Pan Caiyan

Related Institution

Department of Hepatobiliary & Pancreatic Surgery， Zhongnan Hospital of Wuhan University，Hubei Wuhan430071， China； Clinical Medicine Research Center for Mini-Invasive Procedure of Hepatobiliary & Pancreatic Diseases of Hubei Province
Department of Hepatobiliary Surgery，Sun Yat-sen Memorial Hospital，Sun Yat-sen University
The First Clinical College of Hainan Medical University
Department of Hepatobiliary and Pancreatic Surgery，Hainan Cancer Hospital（The Affiliated Cancer Hospital of Hainan Medical University）；Hainan Clinical Medical Research Center of Liver Disease and Liver Critical Illness
Department of Hepatobiliary Surgery， the First Affiliated Hospital of Army Medical University （Southwest Hospital）
0